Qube Research & Technologies LTD Eton Pharmaceuticals, Inc. Transaction History

Qube Research & Technologies LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$11.47 - $20.24 $599,777 - $1.06 Million	-52,291 Reduced 60.21%	34,557 $492,000
Q1 2025 May 15, 2025	SELL	$11.75 - $18.25 $86,162 - $133,827	-7,333 Reduced 7.79%	86,848 $1.13 Million
Q4 2024 Feb 14, 2025	BUY	$5.9 - $13.15 $364,850 - $813,182	61,839 Added 191.2%	94,181 $1.24 Million
Q3 2024 Nov 14, 2024	BUY	$3.28 - $6.0 $106,068 - $194,028	32,338 Added 808450.0%	32,342 $194,000
Q2 2024 Aug 14, 2024	SELL	$3.06 - $3.75 $136,506 - $167,287	-44,610 Reduced 99.99%	4 $0

Q1 2024 May 14, 2024	SELL	$3.48 - $5.03 $20,284 - $29,319	-5,829 Reduced 11.56%	44,614 $167,000
Q4 2023 Feb 13, 2024	BUY	$3.45 - $4.66 $157,616 - $212,896	45,686 Added 960.4%	50,443 $220,000
Q3 2023 Nov 13, 2023	BUY	$2.55 - $5.63 $12,130 - $26,781	4,757 New	4,757 $19,000

103

15.9M

103K

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $428M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.